| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_370ca28a580f6b11f2ed9bd04a153e55 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-705 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-15
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-50 |
| filingDate |
2009-05-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_54efcb3db53fce42cc0fd785a96f1848
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8293ca2f61ad78f69a4362ff74da8ea1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cf47992075a6197b06a13f471d89ee2f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f96526c44536ac3da979083d7246ce7a |
| publicationDate |
2010-11-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
JP-2010263810-A |
| titleOfInvention |
How to determine the side effects or efficacy of erlotinib |
| abstract |
To provide a method for identifying a gene polymorphism associated with the efficacy or side effect of a non-small cell lung cancer therapeutic drug erlotinib and determining the side effect or efficacy of erlotinib using the gene polymorphism. A method for determining side effects or efficacy of a non-small cell lung cancer therapeutic agent erlotinib, comprising detecting at least one gene polymorphism present in an ABCB1 (P-glycoprotein) gene. [Selection figure] None |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2013544843-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2018212320-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11670398-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2016102673-A |
| priorityDate |
2009-05-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |